Immunotech Biopharm Ltd

SEHK:6978 Stock Report

Market Cap: HK$957.1m

Immunotech Biopharm Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 6978?
Owner TypeNumber of SharesOwnership Percentage
Institutions323,0660.0628%
State or Government32,998,6196.41%
Private Companies51,458,40010%
Public Companies97,102,57118.9%
General Public105,412,05820.5%
Individual Insiders227,289,28644.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 14 shareholders own 79.52% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.1%
Zheng Tan
98,194,286HK$182.6m0%no data
18.9%
Tasly Pharmaceutical Group Co., Ltd
97,102,571HK$180.6m0%no data
10%
China Resources Company Limited
51,458,400HK$95.7m0%no data
8.71%
Hyun Chul Jung
44,820,000HK$83.4m0%no data
8.1%
Junzheng Zhang
41,691,428HK$77.5m0%no data
6.41%
Greater Bay Area Development Fund
32,998,619HK$61.4m0%no data
2.67%
Shuhui Wang
13,714,286HK$25.5m0%no data
2.03%
Xiaoou Ma
10,422,857HK$19.4m0%no data
1.33%
Yuning Wang
6,857,143HK$12.8m0%no data
1.07%
Shaobin Ke
5,485,714HK$10.2m0%no data
0.8%
Aiping Song
4,114,286HK$7.7m0%no data
0.39%
MinHui Wang
1,989,286HK$3.7m0%no data
0.063%
China Universal Asset Management Company Ltd.
322,000HK$598.9k0%no data
0.00021%
BMO Asset Management Corp.
1,066HK$2.0k0%no data